A
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Amal Shoeib's research focuses on the molecular pharmacology and potential therapeutic applications of cannabinoids, particularly in the context of cancer. Her work investigates the structure-activity relationships of novel cannabinoid receptor ligands, such as 3-(indanoyl)indoles, and their selectivity for specific cannabinoid receptor subtypes, including CB1 and CB2. Shoeib has characterized the expression of cannabinoid receptors in various human cancer cell lines, including Ewing sarcoma, and explored their role in mediating cell death. Recent publications detail the effects of both natural and synthetic cannabinoids on cancer cell viability, suggesting potential mechanisms involving non-canonical cannabinoid receptors. Her research network includes collaborators at the University of Arkansas for Medical Sciences, with whom she has co-authored multiple publications. Shoeib's scholarship metrics include an h-index of 5, with 10 total publications and 70 citations.
Metrics
- h-index: 5
- Publications: 10
- Citations: 70
Selected Publications
-
Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death (2022)
-
Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development (2021)
-
Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors (2021)
-
Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists (2021)
Collaboration Network
Top Collaborators
Paul L. Prather
University of Arkansas for Medical Sciences (US)
4 shared publications
- Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lori L. Hensley
Jacksonville State University (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Benjamin M. Ford
University of Arkansas for Medical Sciences (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lirit N. Franks
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Alicja Urbaniak
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Azure L. Yarbrough
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Anna Radomińska‐Pandya
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lance Benson
University of Arkansas for Medical Sciences (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death
Shengyu Mu
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death
Harvey F. Fulo
West Virginia University (US)
1 shared publication
- Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists
Christian V. Cabanlong
University of Arkansas for Medical Sciences (US)
1 shared publication
- Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists
Alexander H. Williams
University of Kentucky (US)
1 shared publication
- Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists
Chang‐Guo Zhan
University of Kentucky (US)
1 shared publication
- Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists
Gregory B. Dudley
West Virginia University (US)
1 shared publication
- Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists
Karol Kacprzak
Adam Mickiewicz University in Poznań (PL)
1 shared publication
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Similar Researchers
Based on overlapping research topics
Azure L. Yarbrough
University of Arkansas for Medical Sciences
Cannabis and Cannabinoid Research
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Baku Acharya
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Computational Drug Discovery Methods
Ahmed D. Iqbal
Arkansas State University
Cancer Treatment and Pharmacology
Computational Drug Discovery Methods
Pharmacological Effects and Toxicity Studies
Svetoslav Slavov
National Center for Toxicological Research
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Computational Drug Discovery Methods
Anna Radomińska‐Pandya
University of Arkansas for Medical Sciences
Cannabis and Cannabinoid Research
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Alicja Urbaniak
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Computational Drug Discovery Methods
Pharmacological Effects and Toxicity Studies